Full Grants
|
2021 - 2022 |
|||
|
Beyond RBD: covert REM sleep abnormalities in Parkinson disease |
|||
|
|
The Molecular Mechanism of GDNF Transport in Parkinson Disease |
|||
|
|
Studies on the interplay between mutant GBA1 and mutant LRRK2 alleles in development of Parkinson disease using Drosophila models |
|||
|
| Revealing mechanisms of the lipid scramblase ANO6/TMEM16F in α-synuclein pathological behavior | |||
|
|||
|
2020 - 2021 |
|||
|
Accumulation of the quinolinic acid neurometabolite and cross-seeding of α-synuclein as a novel mechanism and potential treatment target in Parkinson’s disease |
|||
|
|
Establishing a human relevant Brain-On-a-Chip platform for elucidating pathways and cellular dysfunction in Parkinson’s disease |
|||
|
|
Exploring the role of APOE4 expression in the pathology of Parkinson's disease |
|||
|
|||
|
2019 - 2020 |
|||
|
LRRK2-mediated phosphorylation of the Rab GTPase Rab12 as regulator of Rab12 connectivity and axonal transport; Exploring a novel link underlying Parkinson’s disease |
|||
|
|
Inhibition of Exosome Synthesis as a Novel Therapeutic Target for Parkinson's Disease |
|||
|
|
A friend or a foe: the role of cholesterol and its metabolite in α-synuclein cell-to-cell transmission |
|||
|
